Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Anaesthesiol ; 21(5): 379-83, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15141796

RESUMO

BACKGROUND AND OBJECTIVE: Unplanned hospital admission is a measure of quality of care in the setting of day-case surgery. We set out to identify the incidence and causes of unplanned hospital admission in a paediatric day-case unit. METHODS: A retrospective survey to determine the incidence and causes of unplanned hospital admissions in children undergoing day-case surgery. The survey covered the period from January 1996 until December 1999 inclusive in a university affiliated children's hospital. This hospital is the second largest paediatric referral centre in Ireland with total admissions across all specialities during the study period of 42 738. RESULTS: During the study period 10 772 children underwent day-case surgery, of whom 242 (2.2%) experienced unplanned hospital admission. The reasons for admission were surgical 146 (54%), anaesthetic 44 (16%), social 38 (14%), medical 31 (11%) and unclassified 10 (4%). Pain, surgical complications and/or further management, admission for observation, extensive surgery and oozing were the commonest surgical reasons. Postoperative nausea and vomiting, anaesthetic-related complication and somnolence were the commonest anaesthetic causes responsible for admission. Surgery performed after 15:00 h was an important factor associated with admission for social reasons. Orthopaedic surgery accounted for the largest absolute number of unplanned admissions with 61 (25%), followed by urology with 46 (19%) and general surgery with 46 (19%). However, measured as percentage of caseload, urology had the highest proportion of unplanned hospital admissions. CONCLUSION: This study demonstrated that the incidence and causes of unplanned hospital admission following day-case surgery in children are similar to those for adults.


Assuntos
Procedimentos Cirúrgicos Ambulatórios/estatística & dados numéricos , Hospitalização/estatística & dados numéricos , Complicações Pós-Operatórias/epidemiologia , Adolescente , Procedimentos Cirúrgicos Ambulatórios/efeitos adversos , Criança , Pré-Escolar , Feminino , Hospitais Pediátricos/estatística & dados numéricos , Hospitais Universitários/estatística & dados numéricos , Humanos , Incidência , Lactente , Recém-Nascido , Irlanda/epidemiologia , Masculino , Dor Pós-Operatória/epidemiologia , Estudos Retrospectivos
2.
Eur J Anaesthesiol ; 19(1): 32-9, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11913801

RESUMO

BACKGROUND AND OBJECTIVE: Postoperative renal impairment is a recognized complication of infrarenal aortic cross-clamping. Our hypothesis was that the renal vasodilating and natriuretic effects of fenoldopam mesylate, a selective dopamine (DA1) agonist, would preserve renal function in patients undergoing elective infrarenal aortic cross-clamping. METHODS: A prospective, randomized, double blind controlled clinical trial was performed. Twenty-eight ASA II-III patients undergoing elective aortic surgery requiring infrarenal aortic cross-clamping were studied. According to random allocation, patients received either fenoldopam (0.1 microg kg(-1) min(-1)) or placebo intravenously prior to surgical skin incision until release of the aortic clamp. Plasma creatinine, creatinine clearance, urinary output, fractional excretion of sodium, and free water clearance were measured: (a) prior to admission to hospital; (b) during the period from insertion of the urinary catheter until application of the aortic cross-clamp; (c) during the period of aortic cross-clamping; (d) 0-4 h, and (e) 4-8 h after release of the clamp and on days 1, 2, 3, and 5 postoperatively. RESULTS: Fenoldopam (0.1 microg kg(-1)min(-1)) administration was not associated with haemodynamic instability. On application of the aortic cross-clamp creatinine clearance decreased significantly in the placebo (83 +/- 20 to 42 +/- 29 mL min(-1) (mean +/- SD)) (P < 0.01) but not in the fenoldopam group, and this decrease persisted for at least 8 h after release of the cross-clamp (83 +/- 20 to 54 +/- 33 mL min(-1) (mean +/- SD)) (P < 0.05). Plasma creatinine concentration increased significantly from baseline on the first postoperative day in the placebo group (87 +/- 12 to 103 +/- 28 micromolL(-1) (mean +/- SD)) (P < 0.01) but not in the fenoldopam group. CONCLUSIONS: These findings are consistent with the hypothesis that fenoldopam possesses a renoprotective effect during and after infrarenal aortic cross-clamping.


Assuntos
Anti-Hipertensivos/uso terapêutico , Aorta/cirurgia , Fenoldopam/uso terapêutico , Insuficiência Renal/tratamento farmacológico , Idoso , Análise de Variância , Pressão Sanguínea/efeitos dos fármacos , Método Duplo-Cego , Procedimentos Cirúrgicos Eletivos , Feminino , Frequência Cardíaca/efeitos dos fármacos , Humanos , Masculino , Complicações Pós-Operatórias , Estudos Prospectivos , Insuficiência Renal/fisiopatologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA